Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1 AUD | 0.00% | 0.00% | -9.09% |
May. 06 | IDT Australia Secures Victorian Government Funding for Cancer Medication Production Facility | MT |
Apr. 16 | IDT Australia Signs Master Service Agreement with Sanofi | MT |
Business Summary
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Active Pharmaceutical Ingredients and Finished Dose Forms
100.0
%
| 12 | 100.0 % | 7 | 100.0 % | -42.71% |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Australia
100.0
%
| 12 | 100.0 % | 7 | 100.0 % | -42.71% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Paul McDonald
CEO | Chief Executive Officer | - | 20-12-31 |
Director of Finance/CFO | - | 22-09-27 | |
Kagiaros Chris
HRO | Human Resources Officer | - | 21-08-31 |
Phil Wykes
PRN | Corporate Officer/Principal | - | - |
Mark Licciardo
SEC | Corporate Secretary | 60 | 22-10-02 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Simari
CHM | Chairman | 54 | 22-10-09 |
Geoffrey Sam
BRD | Director/Board Member | - | 22-10-09 |
Jane Ryan
BRD | Director/Board Member | 65 | 22-01-27 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 351,479,469 | 299,401,442 ( 85.18 %) | 0 | 85.18 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-9.09% | 23.44M | |
+8.63% | 114B | |
+13.17% | 107B | |
-12.76% | 22.22B | |
-2.33% | 21.28B | |
-5.06% | 18.8B | |
-7.19% | 17.51B | |
-39.93% | 17.17B | |
+6.67% | 14.14B | |
+33.90% | 12.2B |
- Stock Market
- Equities
- IDT Stock
- Company IDT Australia Limited